Covid-19 Impact on Global Herpes Simplex Virus (HSV) Vaccines Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Herpes Simplex Virus (HSV) Vaccines Product Introduction
1.2 Market Segments
1.3 Key Herpes Simplex Virus (HSV) Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Type
1.4.2 GEN-003
1.4.3 VCL-HB01
1.4.4 HSV529
1.4.5 Others
1.5 Market by Application
1.5.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Application
1.5.2 HSV-1 (Oral Herpes)
1.5.3 HSV-2 (Genital Herpes)
1.6 Coronavirus Disease 2019 (Covid-19): Herpes Simplex Virus (HSV) Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Herpes Simplex Virus (HSV) Vaccines Industry
1.6.1.1 Herpes Simplex Virus (HSV) Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Herpes Simplex Virus (HSV) Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Herpes Simplex Virus (HSV) Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Estimates and Forecasts
2.1.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue 2015-2026
2.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales 2015-2026
2.2 Herpes Simplex Virus (HSV) Vaccines Market Size by Region: 2020 Versus 2026
2.2.1 Global Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Herpes Simplex Virus (HSV) Vaccines Competitor Landscape by Players
3.1 Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers
3.1.1 Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers
3.2.1 Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Herpes Simplex Virus (HSV) Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Herpes Simplex Virus (HSV) Vaccines Revenue in 2019
3.2.5 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Herpes Simplex Virus (HSV) Vaccines Price by Manufacturers
3.4 Herpes Simplex Virus (HSV) Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Herpes Simplex Virus (HSV) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Herpes Simplex Virus (HSV) Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Type (2015-2020)
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2015-2020)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2015-2020)
4.1.3 Herpes Simplex Virus (HSV) Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Herpes Simplex Virus (HSV) Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Application (2015-2020)
5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2015-2020)
5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2015-2020)
5.1.3 Herpes Simplex Virus (HSV) Vaccines Price by Application (2015-2020)
5.2 Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Herpes Simplex Virus (HSV) Vaccines by Country
6.1.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country
6.1.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Type
6.3 North America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Herpes Simplex Virus (HSV) Vaccines by Country
7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country
7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Type
7.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines by Region
8.1.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region
8.1.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Herpes Simplex Virus (HSV) Vaccines by Country
9.1.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country
9.1.2 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Type
9.3 Central & South America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines by Country
10.1.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country
10.1.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Products Offered
11.1.5 Sanofi Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Corporation Information
11.3.2 Genocea Biosciences Description, Business Overview and Total Revenue
11.3.3 Genocea Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Products Offered
11.3.5 Genocea Biosciences Recent Development
11.4 Vical
11.4.1 Vical Corporation Information
11.4.2 Vical Description, Business Overview and Total Revenue
11.4.3 Vical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Products Offered
11.4.5 Vical Recent Development
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Products Offered
11.1.5 Sanofi Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Herpes Simplex Virus (HSV) Vaccines Market Estimates and Projections by Region
12.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Herpes Simplex Virus (HSV) Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Herpes Simplex Virus (HSV) Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Herpes Simplex Virus (HSV) Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Herpes Simplex Virus (HSV) Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Herpes Simplex Virus (HSV) Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Herpes Simplex Virus (HSV) Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Herpes Simplex Virus (HSV) Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Herpes Simplex Virus (HSV) Vaccines Market Segments
Table 2. Ranking of Global Top Herpes Simplex Virus (HSV) Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of GEN-003
Table 5. Major Manufacturers of VCL-HB01
Table 6. Major Manufacturers of HSV529
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Herpes Simplex Virus (HSV) Vaccines Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Herpes Simplex Virus (HSV) Vaccines Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Herpes Simplex Virus (HSV) Vaccines Players to Combat Covid-19 Impact
Table 13. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Herpes Simplex Virus (HSV) Vaccines Sales by Regions 2015-2020 (K Units)
Table 16. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Regions (2015-2020)
Table 17. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Manufacturers (2015-2020)
Table 20. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Herpes Simplex Virus (HSV) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2019)
Table 22. Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Price (2015-2020) (USD/Unit)
Table 25. Herpes Simplex Virus (HSV) Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Type
Table 27. Date of International Manufacturers Enter into Herpes Simplex Virus (HSV) Vaccines Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2015-2020) (K Units)
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2015-2020)
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2015-2020)
Table 33. Herpes Simplex Virus (HSV) Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2015-2020) (K Units)
Table 35. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2015-2020)
Table 36. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2015-2020) (K Units)
Table 37. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2015-2020)
Table 38. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2015-2020)
Table 40. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2015-2020) (K Units)
Table 41. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 42. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2015-2020) (K Units)
Table 43. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 44. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2015-2020) (K Units)
Table 45. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2015-2020)
Table 46. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2015-2020)
Table 48. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2015-2020) (K Units)
Table 49. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 50. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2015-2020) (K Units)
Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 60. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2015-2020) (K Units)
Table 61. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2015-2020)
Table 64. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2015-2020) (K Units)
Table 65. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 66. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2015-2020) (K Units)
Table 67. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Table 76. Sanofi Corporation Information
Table 77. Sanofi Description and Major Businesses
Table 78. Sanofi Herpes Simplex Virus (HSV) Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Sanofi Product
Table 80. Sanofi Recent Development
Table 81. GlaxoSmithKline Corporation Information
Table 82. GlaxoSmithKline Description and Major Businesses
Table 83. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Recent Development
Table 86. Genocea Biosciences Corporation Information
Table 87. Genocea Biosciences Description and Major Businesses
Table 88. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Genocea Biosciences Product
Table 90. Genocea Biosciences Recent Development
Table 91. Vical Corporation Information
Table 92. Vical Description and Major Businesses
Table 93. Vical Herpes Simplex Virus (HSV) Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Vical Product
Table 95. Vical Recent Development
Table 96. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 97. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 101. North America: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 103. Europe: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 105. Asia Pacific: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 107. Latin America: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 109. Middle East and Africa: Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Herpes Simplex Virus (HSV) Vaccines Players
Table 114. Herpes Simplex Virus (HSV) Vaccines Customers List
Table 115. Herpes Simplex Virus (HSV) Vaccines Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of FiguresFigure 1. Herpes Simplex Virus (HSV) Vaccines Product Picture
Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. GEN-003 Product Picture
Figure 4. VCL-HB01 Product Picture
Figure 5. HSV529 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020 & 2026
Figure 8. HSV-1 (Oral Herpes)
Figure 9. HSV-2 (Genital Herpes)
Figure 10. Herpes Simplex Virus (HSV) Vaccines Report Years Considered
Figure 11. Global Herpes Simplex Virus (HSV) Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Sales 2015-2026 (K Units)
Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region in 2019
Figure 16. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Herpes Simplex Virus (HSV) Vaccines Revenue in 2019
Figure 20. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2019
Figure 23. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2019
Figure 28. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2019
Figure 33. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Herpes Simplex Virus (HSV) Vaccines Market Share by Type in 2019
Figure 39. North America Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2019
Figure 40. Europe Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Herpes Simplex Virus (HSV) Vaccines Market Share by Type in 2019
Figure 55. Europe Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region in 2019
Figure 60. China Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2019
Figure 84. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Herpes Simplex Virus (HSV) Vaccines Market Share by Type in 2019
Figure 95. Latin America Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2019
Figure 108. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Genocea Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Vical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. North America Herpes Simplex Virus (HSV) Vaccines Sales G